The global clinical decision support systems market size was estimated at USD 5.30 billion in 2023 and is projected to grow at a CAGR of 10.79% from 2024 to 2030. Clinical decision support systems (CDSSs) have experienced significant advancement in recent decades, providing clinicians with vital tools to make informed decisions in patient care. These systems have emerged as a promising means to improve patient outcomes and reduce overall healthcare costs.

AI and ML technologies are transforming the CDSS market, offering advanced functionalities such as predictive analytics, pattern recognition, and tailored recommendations. AI-driven CDSSs can analyze extensive datasets, detect patterns, anticipate outcomes, and suggest optimal treatment strategies. Researchers are integrating AI with CDSS, as demonstrated by the University of Texas at Austin’s Dell Medical School researchers who developed an AI-based CDSS to aid clinicians in discussing nutrition and making decisions with patients about diet improvements in December 2022.

Gather more insights about the market drivers, restrains and growth of the Global Clinical Decision Support Systems Market

Clinical Decision Support Systems Market Segments Highlights:

• The standalone CDSS segment held the market with the largest revenue share of over 30.0% in 2023, because it is widely adopted for its low cost and simplicity.
• The integrated EHR with CDSS segment is expected to grow at the fastest CAGR during the forecast period, driven by increasing EHR adoption in multi-specialty healthcare facilities.
• In April 2023, the U.S. government proposed a rule granting providers more comprehensive access to information within their EHR systems to evaluate CDSS algorithms and outcomes.
• Based on delivery mode, the on premise segment led the market with the largest revenue share of 42.35% in 2023. On-premise CDSS solutions offer flexibility for customization and integration with existing healthcare systems and workflows, catering to specific organizational needs.
• The cloud-based segment is expected to grow at the fastest CAGR over the forecast period. Representing a significant IT advancement, they offer reliability and cost-effectiveness. Enhanced accessibility via mobile platforms and robust data protection mechanisms drive their adoption.
• Based on application, the drug allergy alerts segment held the market with the largest revenue share of over 25.0% in 2023, because it is widely utilized in clinical decision support systems (CDSSs) to enhance patient safety and prevent adverse drug reactions (ADRs).
• Based on component, the services segment led the market with the largest revenue share of 42.49% in 2023. This segment dominated the market as continuous technical support ensures CDSS functionality and performance. In addition, healthcare professionals require training to effectively utilize CDSS, further propelling segment growth.
• The software segment is expected to grow at the fastest CAGR during the forecast period. Integrated with CPOE and EHR software, CDSS software provides enhanced decision support with customized results for individual patients.
• The clinical decision support systems market in North America accounted for the revenue share of 43.76% in 2023. This dominance is fueled by the rising demand for IT solutions in healthcare and the emphasis on delivering quality healthcare services.
• The clinical decision support systems market in U.S. led the North America market. The surge is attributed to hospitals and healthcare institutes' increased adoption of electronic health records (EHRs). According to the Office of the National Coordinator for Health Information Technology, about 78% of physicians and 96% of hospitals in 2021 utilized certified EHR systems.
• The clinical decision support systems market in Europe is poised to maintain a significant share throughout the forecast period. This growth is fueled by the involvement of key market players, increasing acceptance of CDSS, and the establishment of supportive frameworks.
• The clinical decision support systems market in Asia Pacific is expected to grow at the fastest CAGR during the forecast period. In addition, technological advancements, growing healthcare demands, government backing, and increased awareness of the benefits of CDSS are driving market growth.
• The clinical decision support systems market in China is projected to grow at a significant CAGR during the forecast period. The Chinese government actively promotes the adoption of healthcare IT solutions, including CDSS, as part of its healthcare reform efforts.

Browse through Grand View Research's Healthcare IT Industry Research Reports.

• Fitness Tracker Market: The global fitness tracker market size was estimated at USD 60.9 billion in 2024 and is projected to grow at a CAGR of 18.0% from 2025 to 2030.
• Telerehabilitation Market: The global telerehabilitation market size was estimated at USD 5.32 billion in 2024 and is expected to grow at a CAGR of 13.2% from 2025 to 2030.

Recent Development:

• In October 2023, Wolters Kluwer Health launched AI Labs, a collective resource to integrate generative AI with UpToDate, its CDS solution, enabling medical professionals to make better-informed decisions
• In August 2023, GE HealthCare launched CardioVisio for Atrial Fibrillation, a patient-centric, digital CDS tool to allow precision care
• In February 2023, EBSCO Information Services launched new features in DynaMedex Mobile App to improve clinical decision support. These enhancements improve the mobile experience for users by enabling clinicians to deliver evidence-based patient care efficiently
• Moreover, in May 2020, DHIndia announced a partnership with EHRC@IIITB & Healthelife to develop a CDSS for the screening of COVID-19. The partnership also included the formation of a minimal triage application for front-line doctors
• In March 2020, IBM Watson Health partnered with EBSCO Information Services to enhance CDSS and operations for healthcare systems and providers

Key Companies & Market Share Insights:

The global market is fairly competitive. These players are involved in new product launches, product innovations, acquisitions, and partnerships to gain a competitive edge over each other.

The following are the leading companies in the clinical decision support systems market. These companies collectively hold the largest market share and dictate industry trends.

• McKesson Corporation
• Oracle (Cerner Corporation)
• Siemens Healthineers GmbH
• Allscripts Healthcare, LLC
• athenahealth, Inc.
• NextGen Healthcare Inc.
• Koninklijke Philips N.V
• IBM Corporation
• Agfa-Gevaert Group
• Wolters Kluwer N.V.

Order a free sample PDF of the Clinical Decision Support Systems Market Intelligence Study, published by Grand View Research.